. 2021 Dec 30;76(6):1765–1776. doi: 10.22092/ari.2021.356439.1844

Table 3.

Changes in the hematological parameters in the blood of male Sprague-Dawley rats treated with EQ and/or BHT for 45 and 90 days

		HB(g/dl)	RBCS (1086/cmm)	WBCs (1083/cmm)	Platelet (1083/cmm)	D. Leucocytic count%
The main effect
Duration	45 days	11.70 ^a ±0.50	4.00 ^a± 0.22	13.00 ^a±1.00	884.0 ^b±44.00	10.90 ^a±0.70
	90 days	10.60 ^b±0.50	3.59 ^b±0.20	10.60 ^b±0.65	963.0 ^a ±36.00	10.00 ^b±0.70
	Sig.	***	***	***	***	*
Treatments	Control	14.00 ^a±0.40	4.90^a±0.10	16.20 ^a±0.30	1192.0^a±8.00	10.00 ^a±0.20
	VH	14.00 ^a±0.10	4.90 ^a±0.06	15.20 ^a±1.30	1200.0 ^a±48.00	10.00 ^a±0.40
	EQ	10.85^bc±1.10	3.80^bc±0.50	12.90^b±0.30	824.00^c±8.00	7.50^b±1.30
	BHT	11.50 ^b±0.40	4.00 ^b±0.22	13.70 ^b±0.90	931.00 ^b±46.00	9.00 ^ab±0.40
	EQ+ BHT	10.00 ^c±0.30	3.10 ^c±0.17	11.30 ^c±0.40	944.00 ^b±30.00	9.40 ^ab±0.30
	Sig.	***	***	***	***	***
The interaction effect
45 days	Control	14.60 ^a±0.30	5.00 ^a±0.05	16.70 ^a±0.10	1172 ^a±5.00	10.00 ^a±0.40
	VH	14.40 ^a±0.10	5.20 ^a±0.08	16.00 ^a ±0.80	1177 ^a±15.50	10.50 ^a±0.20
	EQ	10.70 ^b±0.30	3.30 ^cd±0.21	13.00 ^b±0.60	832.0 ^b±14.00	8.10 ^c±0.10
	BHT	10.60 ^b±0.10	3.50 ^b±0.12	12.0 ^b±0.40	812.0 ^b±0.04	9.00 ^b±0.30
	EQ+ BHT	10.20 ^b±0.10	2.90 ^de±0.04	11.48 ^c±0.40	815.0 ^b±10.00	9.80 ^b±0.40
90 days	Control	13.60 ^a ±0.80	4.80 ^a±0.18	15.60 ^a± 0.30	1212 ^a±3.00	10.50 ^a±0.20
	VH	13.60 ^a ±0.80	4.6 ^a±0.13	16.40 ^a±1.20	1200 ^a±32.00	10.50 ^a±0.60
	EQ	9.00 ^c ±0.10	2.56 ^e±0.05	12.60 ^b±0.20	816.0 ^d±6.00	6.80 ^d±0.40
	BHT	7.90 ^de±0.30	2.95 ^deᵉ±0.12	12.40 ^b±0.50	819.0 ^d±26.00	9.00 ^b±0.20
	EQ+ BHT	7.00 ^d±0.10	2.96 ^deᵉ±0.26	11.00 ^c±0.70	811.0 ^d±48.00	9.00 ^b± 0.40
	Sig.	***	***	***	***	***

Data are expressed as mean±SD. Means within the same column carrying different superscripts are significant differences (P<0.05) (n=5/group). NS= not significant,*=P<0.05,***=P<0.001.